Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig J Thomas

Showing results (101-110 of 237) with videos related to

Pageof 24
Sort By:
Bioorganic & Medicinal Chemistry|June 23, 2009
Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell deathPing Jun Zhu, John P Hobson, Noel Southall, et al.
Cancers|August 14, 2025
The Kinase Inhibitor GNF-7 Is Synthetically Lethal in Topoisomerase 1-Deficient Ewing SarcomaCarly M Sayers, Morgan B Carter, Haiyan Lei, et al.
British Journal of Pharmacology|April 4, 2019
(R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic dosesPanos Zanos, Jaclyn N Highland, Xin Liu, et al.
ACS Chemical Neuroscience|February 3, 2022
Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2<i>,</i>6)- and (5<i>R</i>)-Methyl-(2<i>R,</i>6<i>R</i>)-hydroxynorketaminesJaclyn N Highland, Patrick J Morris, Kylie M Konrath, et al.
Journal of Medicinal Chemistry|March 12, 2016
Structure Property Relationships of Carboxylic Acid IsosteresPierrik Lassalas, Bryant Gay, Caroline Lasfargeas, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Multiple Epigenetic Mechanisms Functionally Cooperate to Silence Expression of Somatostatin Receptor Type 2 in Pancreatic Neuroendocrine TumorsJames P Madigan, Stephen G Andrews, Rivka B Farrell, et al.
Pharmacological Reviews|March 6, 2021
Hydroxynorketamines: Pharmacology and Potential Therapeutic ApplicationsJaclyn N Highland, Panos Zanos, Lace M Riggs, et al.
Molecular Cancer Therapeutics|May 7, 2020
EWS-FLI1-regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor GrowthSameer H Issaq, Arnulfo Mendoza, Ria Kidner, et al.
Pharmacological Reviews|June 28, 2018
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic MechanismsPanos Zanos, Ruin Moaddel, Patrick J Morris, et al.
Nucleic Acids Research|February 27, 2018
Characterization of clinically used oral antiseptics as quadruplex-binding ligandsDavid R Calabrese, Katherine Zlotkowski, Stephanie Alden, et al.
Pageof 24

Showing results (101-110 of 237) with videos related to

Sort By:
Pageof 24
Bioorganic & Medicinal Chemistry|June 23, 2009
Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell deathPing Jun Zhu, John P Hobson, Noel Southall, et al.
Cancers|August 14, 2025
The Kinase Inhibitor GNF-7 Is Synthetically Lethal in Topoisomerase 1-Deficient Ewing SarcomaCarly M Sayers, Morgan B Carter, Haiyan Lei, et al.
British Journal of Pharmacology|April 4, 2019
(R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic dosesPanos Zanos, Jaclyn N Highland, Xin Liu, et al.
ACS Chemical Neuroscience|February 3, 2022
Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2<i>,</i>6)- and (5<i>R</i>)-Methyl-(2<i>R,</i>6<i>R</i>)-hydroxynorketaminesJaclyn N Highland, Patrick J Morris, Kylie M Konrath, et al.
Journal of Medicinal Chemistry|March 12, 2016
Structure Property Relationships of Carboxylic Acid IsosteresPierrik Lassalas, Bryant Gay, Caroline Lasfargeas, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Multiple Epigenetic Mechanisms Functionally Cooperate to Silence Expression of Somatostatin Receptor Type 2 in Pancreatic Neuroendocrine TumorsJames P Madigan, Stephen G Andrews, Rivka B Farrell, et al.
Pharmacological Reviews|March 6, 2021
Hydroxynorketamines: Pharmacology and Potential Therapeutic ApplicationsJaclyn N Highland, Panos Zanos, Lace M Riggs, et al.
Molecular Cancer Therapeutics|May 7, 2020
EWS-FLI1-regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor GrowthSameer H Issaq, Arnulfo Mendoza, Ria Kidner, et al.
Pharmacological Reviews|June 28, 2018
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic MechanismsPanos Zanos, Ruin Moaddel, Patrick J Morris, et al.
Nucleic Acids Research|February 27, 2018
Characterization of clinically used oral antiseptics as quadruplex-binding ligandsDavid R Calabrese, Katherine Zlotkowski, Stephanie Alden, et al.
Pageof 24